Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

NCT04855617 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT04855617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
October 26, 2020
Completion date
October 1, 2022
Enrollment
122 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis